ABvac-42

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameABvac-42
Drug Alias NameABvac-42
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAraclon Biotech Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAraclon Biotech Sl
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A